Skip to main content

Arterielle Hypertonie als koronarer und zerebrovaskulärer Risikofaktor

  • Conference paper
Herzerkrankungen
  • 20 Accesses

Zusammenfassung

Mehr als 45% aller Todesfälle werden in der Bundesrepublik Deutschland in diesem Jahr kardiovaskulären Ursprungs sein (20). Hauptursachen für diese hohe kardiovaskuläre Mortalität sind koronare Herzerkrankungen und die arterielle Hypertonie (12, 21).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Alexander JK, Peterson KL (1972) Cardiovascular effects of weight reduction. Circulation 45: 310–318

    PubMed  CAS  Google Scholar 

  2. Australian National Blood Pressure Study Management Committee (1980). The Australian therapeutic trial in mild hypertension. Lancet 1: 1261–1267

    Google Scholar 

  3. Berry CL (1978) Hypertension and arterial development - Longterm considerations. Br Heart J 40: 709 - 717

    Article  PubMed  CAS  Google Scholar 

  4. Brandt EN Jr (1982) Zitiert in: United States Medicine 18: Heft 1, S 2 und 8 (Januar)

    Google Scholar 

  5. Carey RM, Ayers CR (1976) Labile hypertension — Precursor of sustained hypertension? Am J Med 61: 811–840

    Article  PubMed  CAS  Google Scholar 

  6. Choquette G, Ferguson RJ (1973) Blood pressure reduction in “borderline” hypertensives following physical training. Can Med Assoc J 108: 699–703

    PubMed  CAS  Google Scholar 

  7. Dahl LK (1977) Salt intake and hypertension. In: Hypertension. Genest J, Koiw E, Kuchel O (eds), Mc Graw Hill, New York, p 548–559

    Google Scholar 

  8. Dawber TR (1980) The Framingham Study. The Epidemiology of Atherosclerotic Disease. Harvard Univ. Press, Cambridge (Mass )

    Google Scholar 

  9. Deutsche Liga zur Bekämpfung des hohen Blutdruckes E. V. (1984) Empfehlungen zur Hochdruckbehandlung in der Praxis und zur Behandlung hypertensiver Notfälle. Heidelberg, 5. Auflage, September

    Google Scholar 

  10. Ditschuneit H, Ditschuneit HH, Wechsler J (1979) Adipositasbehandlung — Nulldiät oder kalorienreduzierte Diät? Nulldiät. Internist 20: 151–158

    PubMed  CAS  Google Scholar 

  11. Fisch IR, Frank J (1977) Oral contraceptives and blood pressure. JAMA 237: 2499–2503

    Article  PubMed  CAS  Google Scholar 

  12. Fröhlich ED (1978) Hypertension and angina pectoris. JAMA 239: 344–345

    Article  PubMed  Google Scholar 

  13. Hany A, Schaub F, Nager F (1965) Die Prognose der behandelten malignen Hypertonie. DMW 90: 18–26

    Article  CAS  Google Scholar 

  14. Hedstrand H, Aberg H (1975) A 3-year follow-up of middle-aged men with borderline blood pressure. Acta Med Scand 198: 389–395

    Article  PubMed  CAS  Google Scholar 

  15. Hypertension Detection and Follow-up Program Cooperative Group: Five year findings of the Hypertension Detection and Follow-up Program I. Reduction in mortality of persons with high blood pressure, including mild hypertension (1979). JAMA 242: 2562–2571

    Google Scholar 

  16. Hypertension Detection and Follow-up Programm Cooperative Group: The effect of treatment on mortality in “mild” hypertension. Results of the Hypertension Detection and Follow-up Program (1982). New Engl J Med 307: 976–980

    Google Scholar 

  17. Julius S (1976) Abnormalities of autonomic nervous control in borderline hypertension. Schweiz Med Wochenschr 106: 1698–1705

    PubMed  CAS  Google Scholar 

  18. Julius S (1977) Borderline hypertension. Epidemiologic and clinical implications. In: Genest J, Koiw E, Kuchel O: Hypertension. Mc Graw Hill, New York, p 630–640

    Google Scholar 

  19. Julius S (1978) Clinical and physiological significance of borderline hypertension at youth. Pediatr Clin North Am 25: 35–45

    PubMed  CAS  Google Scholar 

  20. Junge B, Hoffmeister H (1982) Entwicklung von Herzkrankheiten- und Gesamt-Sterblichkeit. Münch Med Wschr 124: 523–529

    CAS  Google Scholar 

  21. Kannel WB, Schwartz MJ, McNamara PM (1969) Blood pressure and risk of coronary heart disease: The Framingham Study. Dis Chest 56: 43–52

    Google Scholar 

  22. Kannel WB, Brandt N, Skinner JJ, Dawbler TR, McNamara PM (1967) The relation of adiposity to blood pressure and development of hypertension: The Framingham Study. Ann Intern Med 67: 48–59

    Google Scholar 

  23. Kempner W (1948) Treatment of hypertensive vascular disease with rice diet. Am J Med 4: 545–577

    Article  PubMed  CAS  Google Scholar 

  24. Lew EA (1973) High blood pressure, other risk factors and longevity: The insurance viewpoint. Am J Med 55: 281–294

    Article  PubMed  CAS  Google Scholar 

  25. Linss G, Böthig S (1974) Normotonie oder Hypertonie? Dtsch Gesundh-Wes 29: 635–641

    Google Scholar 

  26. Mc Gregor GA, Markandu ND, Best FE, Elder DM, Cam JM, Sagnella GA, Squires M (1982) Double-blind randomised crossover trial of moderate sodium restriction in essential hypertension. Lancet 1: 351–355

    Google Scholar 

  27. Rabkin SW, Mathewson FAL, Hsu PH (1977) Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26 years observation period. The Manitoba study. Am J Cardiol 39: 452–458

    Google Scholar 

  28. Reisin E, Abel R, Modan M, Silverberg DS, Eliahou HE, Modan B (1978) Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N Engl J Med 298:–-6

    Google Scholar 

  29. Report of WHO Expert Committee (1978) Arterial hypertension. World Health Organization, Geneva. Technical Report Series 628

    Google Scholar 

  30. Report of Management Committee of the Australian Therapeutic Trial in Mild Hypertension (1982) “untreated mild hypertension”. A Report. The Lancet 1/185–191

    Google Scholar 

  31. Robertson D, Frölich JC, Carr RK, Watson JT, Hollifield JW, Shand DG, Oates JA (1978) Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med 298: 181–186

    Article  PubMed  CAS  Google Scholar 

  32. Rosenman RH, Sholtz RI, Brand RJ (1976) A study of comparative blood pressure measures in predicting risk of coronary heart disease. Circulation 54: 51–58

    PubMed  CAS  Google Scholar 

  33. Simpson FO, Smirk FH (1962) The treatment of malignant hypertension. Am J Cardiol 9: 868–873

    Article  PubMed  CAS  Google Scholar 

  34. Society of Actuaries Committee on Mortality (1960) Build and blood pressure study 1959. Chicago: Society of Actuaries, p 133–176

    Google Scholar 

  35. Sprackling ME, Mitchell JRA, Short AH, Watt G (1981) Blood pressure reduction in the elderly: a randomised controlled trial of methyldopa. Brit Med J 283: 1151–1153

    Article  CAS  Google Scholar 

  36. Stamler J, Berkson DM, Dyer A, Lepper MH, Lindberg HA, Oglesby P, McKean H, Rhomberg P, Schoenberger JA, Shekelle RB, Stamler R (1975) Relationship of multiple variables to blood pressure-findings from four Chicago epidemiologic studies. In: Oglesby P (ed) Epidemiology and control of hypertension. G. Thieme, Stuttgart, p 307–356

    Google Scholar 

  37. Tuck ML, Sowers J, Dornfeld L, Kledzik G, Maxwall M (1981) The effect of weight reduction on blood pressure, plasma renin activity and plasma aldosterone levels in obese patients. N Engl J Med 304: 930–933

    Article  PubMed  CAS  Google Scholar 

  38. U.S. Public Health Service Study Group (McFate Smith W) (1977) Treatment of mild hypertension. Results of ten-year intervention trial. Circ Res 40 (Suppl I) I-98–I105

    Google Scholar 

  39. Veterans Administration Cooperative Study Group on Antihypertensive Agent (1967) Effects of treatment on morbidity in hypertension. I. Results in patients with diastolic blood pressure averaging 115 through 129 mmHg. JAMA 202: 1028–1034

    Article  Google Scholar 

  40. Veterans Administration Cooperative Study Group on Antihypertensive Agents (1970) Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mmHg. JAMA 213: 1143–1152

    Article  Google Scholar 

  41. Veterans Administration Cooperative Study Group on Antihypertensive Agents (1972) Effects of treatment on morbidity in hypertension. III. Influence of age, diastolic pressure, and prior cardiovascular disease: further analysis of side effects. Circulation 45: 991–1004

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt

About this paper

Cite this paper

Fassbinder, W. (1986). Arterielle Hypertonie als koronarer und zerebrovaskulärer Risikofaktor. In: Loskot, F. (eds) Herzerkrankungen. Steinkopff. https://doi.org/10.1007/978-3-642-72395-7_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-72395-7_1

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-642-72396-4

  • Online ISBN: 978-3-642-72395-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics